{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T02:07:31Z","timestamp":1793844451255,"version":"4.6.1"},"reference-count":30,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background\/Objective: This study\u2019s aim is to evaluate the anatomical and functional effects of selective retina therapy (SRT) in patients with central serous chorioretinopathy (CSC) accompanied by serous pigment epithelial detachment (PED). Methods: This retrospective study included 32 eyes from 32 patients with CSC and serous PED treated with SRT. Pulse energy and micropulse number were adjusted based on test spot visibility on fundus photographs. Best-corrected visual acuity (BCVA; logMAR), central foveal thickness (CFT), subretinal fluid (SRF) height, PED height, and subfoveal choroidal thickness were assessed at baseline and at 1, 2, and 3 months post-treatment. Retinal sensitivity was evaluated using microperimetry at baseline and 3 months. Results: At 3 months after SRT, complete SRF resolution was achieved in 78.1% of eyes (25\/32). Mean BCVA improved significantly from 0.29 \u00b1 0.30 logMAR at baseline to 0.20 \u00b1 0.29 logMAR (p = 0.006). Mean CFT decreased from 284.7 \u00b1 91.3 \u00b5m to 165.7 \u00b1 94.8 \u00b5m (p &lt; 0.001). Mean SRF height decreased from 150.5 \u00b1 74.6 \u00b5m to 20.9 \u00b1 48.3 \u00b5m (p &lt; 0.001), and mean PED height decreased from 101.7 \u00b1 96.9 \u00b5m to 33.3 \u00b1 37.6 \u00b5m (p &lt; 0.001). Retinal sensitivity showed a non-significant improvement at 3 months (p = 0.108). Reduction in PED height was moderately correlated with reduction in SRF height (r = 0.446, p = 0.011). Conclusions: SRT was associated with reductions in PED and SRF in CSC. These findings should be interpreted cautiously given the absence of a control group and the potential for spontaneous changes in SRF and PED.<\/jats:p>","DOI":"10.3390\/jcm15103905","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T11:53:10Z","timestamp":1779191590000},"page":"3905","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Effects of Selective Retina Therapy on Central Serous Chorioretinopathy with Serous Pigment Epithelial Detachments"],"prefix":"10.3390","volume":"15","author":[{"given":"Dayeong","family":"Kim","sequence":"first","affiliation":[{"name":"Graduate School, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung Hee","family":"Jeon","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Science, Yeouido St. Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, Seoul 07345, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7294-6813","authenticated-orcid":false,"given":"Young-Jung","family":"Roh","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Science, Yeouido St. Mary\u2019s Hospital, College of Medicine, The Catholic University of Korea, Seoul 07345, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1600-0420.2007.00889.x","article-title":"Central serous chorioretinopathy","volume":"86","author":"Wang","year":"2008","journal-title":"Acta Ophthalmol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1442-9071.2012.02848.x","article-title":"Central serous chorioretinopathy: A review of epidemiology and pathophysiology","volume":"41","author":"Liew","year":"2013","journal-title":"Clin. Exp. Ophthalmol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1007\/s40123-023-00658-4","article-title":"Risk of central serous chorioretinopathy in male androgen abusers","volume":"12","author":"Subhi","year":"2023","journal-title":"Ophthalmol. Ther."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1136\/bjo.68.11.815","article-title":"Long-term follow-up of central serous chorioretinopathy","volume":"68","author":"Gilbert","year":"1984","journal-title":"Br. J. Ophthalmol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/00006982-200202000-00004","article-title":"Factors associated with reduced visual acuity during long-term follow-up of patients with idiopathic central serous chorioretinopathy","volume":"22","author":"Loo","year":"2002","journal-title":"Retina"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0161-6420(01)00951-4","article-title":"Clinical characteristics of central serous chorioretinopathy in women","volume":"109","author":"Perkins","year":"2002","journal-title":"Ophthalmology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1097\/IAE.0b013e3182993f66","article-title":"Multimodal imaging of pigment epithelial detachment: A guide to evaluation","volume":"33","author":"Mrejen","year":"2013","journal-title":"Retina"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2147\/OPTH.S115685","article-title":"Chronic central serous chorioretinopathy: Long-term follow-up and vision-related quality of life","volume":"11","author":"Breukink","year":"2017","journal-title":"Clin. Ophthalmol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1007\/s00417-006-0277-7","article-title":"Three-dimensional optical coherence tomographic findings in central serous chorioretinopathy","volume":"244","author":"Mitarai","year":"2006","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"4659","DOI":"10.1167\/iovs.12-10991","article-title":"Optical coherence tomography-assisted enhanced depth imaging of central serous chorioretinopathy","volume":"54","author":"Yang","year":"2013","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"101236","DOI":"10.1016\/j.preteyeres.2024.101236","article-title":"Central serous chorioretinopathy: An evidence-based treatment guideline","volume":"101","author":"Feenstra","year":"2024","journal-title":"Prog. Retin. Eye Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1136\/bjo.72.11.829","article-title":"Long-term follow-up of a prospective trial of argon laser photocoagulation in the treatment of central serous retinopathy","volume":"72","author":"Ficker","year":"1988","journal-title":"Br. J. Ophthalmol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"693","DOI":"10.3928\/1542-8877-19970801-16","article-title":"Evaluation of visual function following argon laser photocoagulation in central serous retinopathy","volume":"28","author":"Khosla","year":"1997","journal-title":"Ophthal Surg. Lasers"},{"key":"ref_14","first-page":"51","article-title":"Selective retina therapy (SRT): A review on methods, techniques, preclinical and first clinical results","volume":"302","author":"Brinkmann","year":"2006","journal-title":"Bull. Soc. Belge Ophtalmol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1167\/tvst.15.1.24","article-title":"Selective retina therapy with fundus image\u2013based titration in central serous chorioretinopathy: Prospective outcomes and predictive factors","volume":"15","author":"Jeon","year":"2026","journal-title":"Transl. Vis. Sci. Technol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s40942-025-00741-x","article-title":"Selective retina therapy for central serous chorioretinopathy with focal choroidal excavation: A retrospective case series of six eyes","volume":"11","author":"Jeon","year":"2025","journal-title":"Int. J. Retin. Vitr."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Jeon, S.H., Kim, M., and Roh, Y.J. (2024). Use of a fundus image-based titration strategy for selective retina therapy for central serous chorioretinopathy. J. Clin. Med., 13.","DOI":"10.3390\/jcm13175230"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ophtha.2018.08.010","article-title":"A comparison between the Compass fundus perimeter and the Humphrey Field Analyzer","volume":"126","author":"Montesano","year":"2019","journal-title":"Ophthalmology"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1159\/000515148","article-title":"Clinical perspectives and trends: Microperimetry as a trial endpoint in retinal disease","volume":"244","author":"Yang","year":"2021","journal-title":"Ophthalmologica"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1136\/bjo.2009.178327","article-title":"Selective retina therapy for acute central serous chorioretinopathy","volume":"95","author":"Klatt","year":"2011","journal-title":"Br. J. Ophthalmol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00417-016-3441-8","article-title":"Retinal sensitivity after selective retina therapy (SRT) on patients with central serous chorioretinopathy","volume":"255","author":"Yasui","year":"2017","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1007\/s00417-017-3672-3","article-title":"Selective retina therapy with automatic real-time feedback-controlled dosimetry for chronic central serous chorioretinopathy in Korean patients","volume":"255","author":"Park","year":"2017","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s10384-023-00978-9","article-title":"Practical treatment options for persistent central serous chorioretinopathy and early visual and anatomical outcomes","volume":"67","author":"Kyo","year":"2023","journal-title":"Jpn. J. Ophthalmol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1097\/IAE.0b013e318156db8a","article-title":"The natural history of pigment epithelial detachment associated with central serous chorioretinopathy","volume":"27","author":"Mudvari","year":"2007","journal-title":"Retina"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1097\/IAE.0000000000002108","article-title":"Photodynamic therapy for symptomatic subfoveal retinal pigment epithelial detachment in central serous chorioretinopathy: Outcomes and prognostic factors","volume":"39","author":"Hwang","year":"2019","journal-title":"Retina"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1097\/IAE.0000000000003363","article-title":"Efficacy of half-dose photodynamic therapy versus high-density subthreshold micropulse laser for treating pigment epithelial detachments in chronic central serous chorioretinopathy","volume":"42","author":"Feenstra","year":"2022","journal-title":"Retina"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1136\/bjophthalmol-2020-316076","article-title":"Analysis of choriocapillaris perfusion and choroidal layer changes in patients with chronic central serous chorioretinopathy randomised to micropulse laser or photodynamic therapy","volume":"105","author":"Ho","year":"2021","journal-title":"Br. J. Ophthalmol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.survophthal.2017.09.008","article-title":"Restorative retinal laser therapy: Present state and future directions","volume":"63","author":"Chhablani","year":"2018","journal-title":"Surv. Ophthalmol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1007\/s00347-006-1415-7","article-title":"Selektive Retina-Therapie bei Retinopathia centralis serosa mit Pigmentepithelabhebung","volume":"103","author":"Klatt","year":"2006","journal-title":"Ophthalmologe"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1097\/IAE.0b013e3182680a66","article-title":"Type 1 (sub-retinal pigment epithelial) neovascularization in central serous chorioretinopathy masquerading as neovascular age-related macular degeneration","volume":"32","author":"Fung","year":"2012","journal-title":"Retina"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/10\/3905\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T12:26:47Z","timestamp":1779193607000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/10\/3905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,19]]},"references-count":30,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["jcm15103905"],"URL":"https:\/\/doi.org\/10.3390\/jcm15103905","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,19]]}}}